NTX-023-1

N/A

Report date: 2025/01/26 17:37:57

NME

Base Information

Drug NameNTX-023-1

Drug Alias NameNTX-023-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBile acid receptor FXR agonists

TargetsBile acid receptor FXR

Therapy Area/IndicationsFatty Liver

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArdelyx Inc

China Registration ClassN/A

Active CompaniesArdelyx Inc

Inactive CompaniesN/A

Active IndicationsFatty Liver

Inactive IndicationsN/A

ATC CodeN/A